Namrata Singh, MD, MSCI, FACP
Assistant Professor, UW Department of Medicine, Division of Rheumatology in Internal Medicine

Dr. Singh is presenting work regarding impact of hydroxychloroquine on MACE events in patients with rheumatoid arthritis and effect of rheumatic diseases on birth outcomes. 
Namrata Singh is an adult rheumatologist who recently joined the UWMC in Oct 2019. Before this, she was a faculty at the Univ of Iowa. That is also where she obtained her Masters in Clinical Investigation in 2017. Dr. Singh’s research focuses on the comparative safety and risks of drugs used to treat rheumatic diseases on cancer, cardiovascular and maternal outcomes.  She has also been site PI or co-PI of few clinical trials evaluating efficacy and safety of new therapeutics in Rheumatoid arthritis and Still’s disease.